EP2970455
And-C5 mótefni sem hafa bætta lyfjahvarfafræði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.3.2015EP published:
31.8.2016EP application number:
15710396.1
EP translation filed:
7.9.2016Grant published:
15.10.2016EPO information:
European Patent Register
Max expiry date:
5.3.2035Expiry date:
5.3.2027Next due date:
31.3.2027
Title:
ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS
Timeline
Today
6.3.2015EP application
31.8.2016EP Publication
7.9.2016Translation submitted
15.10.2016Registration published
5.3.2027Expires
Owner
Name:
Alexion Pharmaceuticals, Inc.Address:
352 Knotter Drive, 06410, Cheshire, CT, US
Inventor
Name:
ANDRIEN, Bruce, A., Jr.Address:
Guilford, CT, US
Name:
SHERIDAN, Douglas, L.Address:
Branford, CT, US
Name:
TAMBURINI, Paul, P.Address:
Kensington, CT, US
Name:
WANG, YiAddress:
Woodbridge, Connecticut, CT, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461949932 PDate:
7.3.2014Country:
US
Classification
Categories:
C07K 16/18, C07K 16/40, A61P 29/00, A61P 37/06
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 20.2.2017
Expires: 5.3.2018
Payer: Sigurjónsson & Thor ehf.
Number: 4
Paid: 20.2.2018
Expires: 5.3.2019
Payer: Sigurjónsson & Thor ehf.
Number: 5
Paid: 19.2.2019
Expires: 5.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 26.2.2020
Expires: 5.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 18.2.2021
Expires: 5.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.2.2022
Expires: 5.3.2023
Payer: Patice ehf.
Number: 9
Paid: 20.2.2023
Expires: 5.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.2.2024
Expires: 5.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 26.2.2025
Expires: 5.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.3.2026
Expires: 5.3.2027
Payer: Árnason Faktor ehf.